News

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...
Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a widely used diabetes and weight loss drug, could also be beneficial in ...
Hims & Hers has risen 70% since November 2024, outperforming the S&P 500, despite recent regulatory challenges impacting its compounded semaglutide product. Its diversified portfolio in men's and ...